Skip to main content
About Us
Image Credits
Contributor Info
RSS
Log In
Join
Twitter
E-Alerts
Visit StemJournal
Main menu
About
Image Credits
Contributor Info
E-Alerts
Chapters
Cellular and nuclear reprogramming
Ectoderm specification and differentiation
Endoderm specification and differentiation
Epigenetics
Genomics and proteomics
Germ cell and somatic stem cell biology in reproduction
Manufacturing
Mesoderm specification and differentiation
Niche biology, homing, and migration
Renewal
Stem cell immunology
Therapeutic prospects
Tissue engineering
Protocols
Ectoderm differentiation
Endoderm differentiation
Genome editing
Mesoderm differentiation
Pluripotent stem cells
PSC characterization
PSC genetic stability
Reprogramming
StemLabs
Stem Cell COREdinates
Core Facility Profiles
Boston Children's Hospital Human Neuron Core
Boston University Center for Regenerative Medicine iPSC Core
Columbia Stem Cell Initiative Stem Cell Core Facility
Harvard Stem Cell Institute iPS Core Facility
Stem Cell Protocols
Stem Cell Reagents
Other Resources
News & Profiles
Latest News
Stem Cell Institute Profiles
Journal Stream
Forum
Search form
Search
You are here
Home
Biblio
Author
[
Title
]
Type
Year
Filters:
Author
is
Hegenbart, Ute
[Clear All Filters]
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
D
Niederwieser D
,
Lang T
,
Krahl R
,
Heinicke T
,
Maschmeyer G
,
Al-Ali HKathrin
,
Schwind S
,
Jentzsch M
,
Cross M
,
Kahl C
, et al.
Different treatment strategies versus a common standard arm (CSA) in patients with newly diagnosed AML over the age of 60 years: a randomized German inter-group study.
Ann Hematol. 2023.
PubMed
Google Scholar
F
Korell F
,
Schönland S
,
Schmitt A
,
Jansen M
,
Farid K
,
Müller-Tidow C
,
Dreger P
,
Schmitt M
,
Hegenbart U
.
First third-generation CAR T cell application targeting CD19 for the treatment of systemic IgM AL amyloidosis with underlying marginal zone lymphoma.
Biomark Res. 2023;11(1):91.
PubMed
Google Scholar
G
Sanchorawala V
,
Boccadoro M
,
Gertz M
,
Hegenbart U
,
Kastritis E
,
Landau H
,
Mollee P
,
Wechalekar A
,
Palladini G
.
Guidelines for high dose chemotherapy and stem cell transplantation for systemic AL amyloidosis: EHA-ISA working group guidelines.
Amyloid. 2021:1-7.
PubMed
Google Scholar
H
Dietrich S
,
Okun JG
,
Schmidt K
,
Falk CS
,
Wagner AH
,
Karamustafa S
,
Radujkovic A
,
Hegenbart U
,
Ho AD
,
Dreger P
, et al.
High pre-transplant serum nitrate levels predict risk of acute steroid-refractory graft-versus-host disease in the absence of statins.
Haematologica. 2013.
PubMed
Google Scholar
I
John L
,
Sauer S
,
Hegenbart U
,
Dreger P
,
Hundemer M
,
Müller-Tidow C
,
Schmitt A
,
Schmitt M
,
Raab MS
,
Schönland SO
.
Idecabtagene vicleucel is well tolerated and effective in relapsed/refractory myeloma patients with prior allogeneic stem cell transplantation.
Transplant Cell Ther. 2023.
PubMed
Google Scholar
Scheffold A
,
Jebaraj BMichael Ch
,
Jaramillo S
,
Tausch E
,
Steinbrecher D
,
Hahn M
,
Böttcher S
,
Ritgen M
,
Bunjes D
,
Zeis M
, et al.
Impact of telomere length on the outcome of allogeneic stem cell transplantation for poor-risk chronic lymphocytic leukaemia: results from the GCLLSG CLL3X trial.
Br J Haematol. 2016.
PubMed
Google Scholar
Oubari S
,
Naser E
,
Papathanasiou M
,
Luedike P
,
Hagenacker T
,
Thimm A
,
Rischpler C
,
Kessler L
,
Kimmich C
,
Hegenbart U
, et al.
Impact of time to diagnosis on Mayo stages, treatment outcome and survival in patients with AL amyloidosis and cardiac involvement.
Eur J Haematol. 2021.
PubMed
Google Scholar
M
Palladini G
,
Schönland S
,
Merlini G
,
Milani P
,
Jaccard A
,
Bridoux F
,
Dimopoulos MA
,
Ravichandran S
,
Hegenbart U
,
Roeloffzen W
, et al.
The management of light chain (AL) amyloidosis in Europe: clinical characteristics, treatment patterns, and efficacy outcomes between 2004 and 2018.
Blood Cancer J. 2023;13(1):19.
PubMed
Google Scholar
O
Middeke JM
,
Fang M
,
Cornelissen JJ
,
Mohr B
,
Appelbaum FR
,
Stadler M
,
Sanz J
,
Baurmann H
,
Bug G
,
Schäfer-Eckart K
, et al.
Outcome of patients with abnl(17p) acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation.
Blood. 2014.
PubMed
Google Scholar
P
Dietrich S
,
Radujkovic A
,
Stölzel F
,
Falk CS
,
Benner A
,
Schaich M
,
Bornhäuser M
,
Ehninger G
,
Krämer A
,
Hegenbart U
, et al.
Pretransplant Metabolic Distress Predicts Relapse of Acute Myeloid Leukemia After Allogeneic Stem Cell Transplantation.
Transplantation. 2014.
PubMed
Google Scholar
Radujkovic A
,
Becker N
,
Benner A
,
Penack O
,
Platzbecker U
,
Stölzel F
,
Bornhäuser M
,
Hegenbart U
,
Ho AD
,
Dreger P
, et al.
Pre-transplant weight loss predicts inferior outcome after allogeneic stem cell transplantation in patients with myelodysplastic syndrome.
Oncotarget. 2015.
PubMed
Google Scholar